These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23445751)

  • 1. Inhaled corticosteroids and the increased risk of pneumonia.
    Marzoratti L; Iannella HA; Waterer GW
    Ther Adv Respir Dis; 2013 Aug; 7(4):225-34. PubMed ID: 23445751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
    Yang M; Du Y; Chen H; Jiang D; Xu Z
    Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic effects of inhaled corticosteroids.
    Ernst P; Suissa S
    Curr Opin Pulm Med; 2012 Jan; 18(1):85-9. PubMed ID: 22112998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled corticosteroids and risk of pneumonia: evidence for and against the proposed association.
    Singanayagam A; Chalmers JD; Hill AT
    QJM; 2010 Jun; 103(6):379-85. PubMed ID: 20231237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How and when to use inhaled corticosteroids in chronic obstructive pulmonary disease?
    Antón E
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):25-32. PubMed ID: 23551021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
    Singh S; Amin AV; Loke YK
    Arch Intern Med; 2009 Feb; 169(3):219-29. PubMed ID: 19204211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?
    Festic E; Scanlon PD
    Am J Respir Crit Care Med; 2015 Jan; 191(2):141-8. PubMed ID: 25409118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids.
    O'Byrne PM; Rennard S; Gerstein H; Radner F; Peterson S; Lindberg B; Carlsson LG; Sin DD
    Respir Med; 2012 Nov; 106(11):1487-93. PubMed ID: 22902134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.
    Andreeva-Gateva PA; Stamenova E; Gatev T
    Postgrad Med; 2016 Jun; 128(5):474-84. PubMed ID: 27153510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC; Hurst MM
    Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroids in COPD: a controversy.
    Barnes PJ
    Respiration; 2010; 80(2):89-95. PubMed ID: 20501985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
    Thornton Snider J; Luna Y; Wong KS; Zhang J; Chen SS; Gless PJ; Goldman DP
    Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids for chronic obstructive pulmonary disease.
    Cazzola M; Rogliani P; Novelli L; Matera MG
    Expert Opin Pharmacother; 2013 Dec; 14(18):2489-99. PubMed ID: 24138334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of pneumonia in patients with asthma taking inhaled corticosteroids.
    O'Byrne PM; Pedersen S; Carlsson LG; Radner F; Thorén A; Peterson S; Ernst P; Suissa S
    Am J Respir Crit Care Med; 2011 Mar; 183(5):589-95. PubMed ID: 20889908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ; Au DH; Fitzgibbon ML; Lee TA
    Respir Med; 2010 Feb; 104(2):246-52. PubMed ID: 19879745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between inhaled corticosteroids and upper respiratory tract infection in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
    Chen H; Feng Y; Wang K; Yang J; Du Y
    BMC Pulm Med; 2020 Oct; 20(1):282. PubMed ID: 33115481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
    Gibson PG; Powell H; Ducharme FM
    J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD: A Meta-analysis of 60 Randomized Controlled Trials.
    Chen H; Deng ZX; Sun J; Huang Q; Huang L; He YH; Ma C; Wang K
    Chest; 2023 Jan; 163(1):100-114. PubMed ID: 35921883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.